Tag: Statins
Statin Use Linked to Reduced Risk for Intracerebral Hemorrhage
Risk reduced for lobar and nonlobar intracerebral hemorrhage; greater reductions seen with prolonged use ≥5 years
Clinician Nudge Ups Initiation of Statin Prescribing in Primary Care
Clinician nudge alone or in combination with a patient nudge increases initiation of statin prescribing versus usual care
Cardiovascular Benefits of Statins Outweigh Low Risk for Muscle Symptoms
Only one of 15 muscle symptom-related reports by study participants assigned to statins believed to be due to statins
Guidance Developed for Addressing Use of Nonstatin Therapies
Expert consensus decision pathway developed for patients currently taking statins and needing additional treatment
USPSTF Recommends Statins for Primary Prevention of CVD in Adults
Statin use recommended for adults aged 40 to 75 years with at least one CVD risk factor and estimated 10-year CVD event risk of ≥10 percent
Real-World Data Links Rosuvastatin to Adverse Effects on Kidneys
Greater risks for hematuria, proteinuria seen with higher rosuvastatin dose
Genetic Variants in HMGCR Linked to Increased Cataract Risk
Heterozygous carriers of HMGCR predicted loss-of-function variants had higher risks for developing cataract, cataract surgery
USPSTF Updates Guidance on Statins for Primary Prevention of CVD
Statin use recommended for people aged 40 to 75 years with CV risk factor(s) and higher 10-year risk for a CV event
More Intensive LDL-C Lowering May Cut Recurrent Stroke Risk
More intensive LDL-C-lowering with statin-based therapies linked to reduced risk for recurrent stroke for patients with evidence of atherosclerosis
Meta-Analysis Shows Prevalence of Statin Intolerance Is Low
Prevalence of SI was 9.1 percent overall; significant associations seen for age, female gender, Asian and Black race, obesity, diabetes mellitus
